BRD4 and nut midline carcinoma: Direct suppression of BRD4-NUT and concurrent downregulation of other tumor promoting genes such as EGFR and CDK2 by miR-3140 may potentially overcome resistance to BET inhibitors in NMC cells, although further studies are needed to clarify the acquired resistance of BET inhibitiors.